GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » Research & Development

Pulsion Medical Systems SE (LTS:0NFX) Research & Development : €1.85 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Pulsion Medical Systems SE's Research & Development for the six months ended in Dec. 2023 was €1.85 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €1.85 Mil.


Pulsion Medical Systems SE Research & Development Historical Data

The historical data trend for Pulsion Medical Systems SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE Research & Development Chart

Pulsion Medical Systems SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.57 2.60 2.41 2.49 1.85

Pulsion Medical Systems SE Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.57 2.60 2.41 2.49 1.85

Pulsion Medical Systems SE Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €1.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulsion Medical Systems SE  (LTS:0NFX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Pulsion Medical Systems SE Research & Development Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulsion Medical Systems SE Business Description

Traded in Other Exchanges
N/A
Address
Hans-Riedl-Street 17, Feldkirchen, DEU, 85622
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE Headlines

No Headlines